Stemline Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells

Key Ratios

Key Ratios

Price & Volume

Recent Price $19.65
52 Week High $20.20
52 Week Low $7.30
Volume (10 Day Average) (Mil) $0.21
Beta $0.03

Dividends

Yield (%) --
Ex-Dividend Date
Dividend Rate --%

Financial Strength

Quick Ratio (MRQ) --
Current Ratio (MRQ) $5.14
LT Debt to Equity (MRQ) (%) --
Total Debt to Equity (MRQ) (%) --

Valuation

P/E (TTM) --
Price to Revenue (TTM) $991.37
Price to Cash Flow (TTM) --
Price to Book (MRQ) $6.75

Per Share

Revenue/Share (TTM) $0.02
EPS Fully Diluted (MRQ) $-0.69
Book Value/Share (MRQ) $2.91
Cash Flow/Share (TTM) $-2.95
Cash (MRQ) $3.29

Management Effectiveness

Return on Equity (TTM) (%) -79.10
Return on Assets (TTM) (%) -66.92
Return on Investment (TTM) (%) -79.02

Profitability

Operating Margin (TTM) (%) -12,110.28
Net Profit Margin (TTM) (%) -11,970.46
Gross Margin (TTM) (%) --


Copyright 2018 - Stemline Therapeutics, Inc. All rights reserved